Identify. Justify.
Verify.
A shared governance loop designed to connect what happens at the bedside with the record that follows it.
Identify.
An iOS tablet app uses LiDAR and computer vision for 3D wound measurement.
Justify.
The planned workflow assembles clinical documentation against applicable coverage criteria before claim submission.
Verify.
A cryptographically bound audit chain is designed to keep tamper-evident records and support a read-only federal audit node.
The next therapy
starts with a record.
The platform is designed to be therapy-agnostic: from a graft application today to a research protocol tomorrow.
Planned research workflows extend the same approach to patient assessment, consent, protocol-defined dosing, follow-up and product traceability. Their readiness should be assessed separately from the in-market measurement app.
21 provisional filings.
Four connected areas.
Filed September 15–21, 2026. Provisional applications are not issued patents.
Designed around the work ahead.
Visual wound-status signals; biofilm detection and disruption; endogenous repair-signal capture; flowable formats; battery-free monitoring; tissue custody and provenance.
Concepts and development directions, not a statement that these functions are commercially available or that patents have issued.
Patent issuance, scope and commercial value are uncertain. Conversion of the provisional applications is due by September 2027.
Explore the workflow with us.
For providers, facilities, payors and research partners.
HEAL WELL. AGE WELL. LIVE LONGER.